Literature DB >> 28628039

ChREBP refines the hepatic response to fructose to protect the liver from injury.

Angela M Hall, Brian N Finck.   

Abstract

Overconsumption of fructose and other sugars has been linked to nonalcoholic fatty liver disease (NAFLD); however, the sugar-associated effects that lead to disease are poorly defined. In this issue of the JCI, Zhang and colleagues show that the carbohydrate response element-binding protein (ChREBP) coordinates an adaptive response to a high-fructose diet in mice and that loss of this transcription factor leads to hepatic inflammation and early signs of fibrosis. Intriguingly, ChREBP-dependent effects were due to an exaggerated activation of the proapoptotic arms of the endoplasmic reticulum stress response that is probably secondary to inappropriate derepression of cholesterol biosynthesis. These findings suggest that a previously unknown link exists between ChREBP and the regulation of cholesterol synthesis that affects liver injury.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28628039      PMCID: PMC5490753          DOI: 10.1172/JCI95008

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response.

Authors:  A Bertolotti; Y Zhang; L M Hendershot; H P Harding; D Ron
Journal:  Nat Cell Biol       Date:  2000-06       Impact factor: 28.824

2.  Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity.

Authors:  Deqiang Zhang; Xin Tong; Kyle VanDommelen; Neil Gupta; Kenneth Stamper; Graham F Brady; Zhuoxian Meng; Jiandie Lin; Liangyou Rui; M Bishr Omary; Lei Yin
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

3.  The role of the carbohydrate response element-binding protein in male fructose-fed rats.

Authors:  Derek M Erion; Violetta Popov; Jennifer J Hsiao; Daniel Vatner; Kisha Mitchell; Shin Yonemitsu; Yoshio Nagai; Mario Kahn; Matthew P Gillum; Jianying Dong; Susan F Murray; Vara Prasad Manchem; Sanjay Bhanot; Gary W Cline; Gerald I Shulman; Varman T Samuel
Journal:  Endocrinology       Date:  2012-11-16       Impact factor: 4.736

Review 4.  The unfolded protein response: controlling cell fate decisions under ER stress and beyond.

Authors:  Claudio Hetz
Journal:  Nat Rev Mol Cell Biol       Date:  2012-01-18       Impact factor: 94.444

Review 5.  The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis.

Authors:  Mark A Herman; Varman T Samuel
Journal:  Trends Endocrinol Metab       Date:  2016-07-04       Impact factor: 12.015

6.  A lipidomic analysis of nonalcoholic fatty liver disease.

Authors:  Puneet Puri; Rebecca A Baillie; Michelle M Wiest; Faridoddin Mirshahi; Jayanta Choudhury; Onpan Cheung; Carol Sargeant; Melissa J Contos; Arun J Sanyal
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

7.  Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease.

Authors:  Hae-Ki Min; Ashwani Kapoor; Michael Fuchs; Faridoddin Mirshahi; Huiping Zhou; James Maher; John Kellum; Russell Warnick; Melissa J Contos; Arun J Sanyal
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

8.  Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease.

Authors:  Puneet Puri; Faridoddin Mirshahi; Onpan Cheung; Ramesh Natarajan; James W Maher; John M Kellum; Arun J Sanyal
Journal:  Gastroenterology       Date:  2007-10-26       Impact factor: 22.682

9.  Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease.

Authors:  Mariana Verdelho Machado; Gregory Alexander Michelotti; Guanhua Xie; Thiago Almeida Pereira; Thiago Pereira de Almeida; Jerome Boursier; Brittany Bohnic; Cynthia D Guy; Anna Mae Diehl
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

10.  A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.

Authors:  Ffolliott M Fisher; MiSung Kim; Ludivine Doridot; Jeremy C Cunniff; Thomas S Parker; Daniel M Levine; Marc K Hellerstein; Lisa C Hudgins; Eleftheria Maratos-Flier; Mark A Herman
Journal:  Mol Metab       Date:  2016-11-23       Impact factor: 7.422

View more
  3 in total

Review 1.  Curcumin and dietary polyphenol research: beyond drug discovery.

Authors:  Tian-Ru Jin
Journal:  Acta Pharmacol Sin       Date:  2018-03-15       Impact factor: 6.150

Review 2.  Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease.

Authors:  Kasper W Ter Horst; Mireille J Serlie
Journal:  Nutrients       Date:  2017-09-06       Impact factor: 5.717

Review 3.  Role of de novo cholesterol synthesis enzymes in cancer.

Authors:  Jie Yang; Lihua Wang; Renbing Jia
Journal:  J Cancer       Date:  2020-01-17       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.